Adriyamisin-siklofosfamid kemoterapisi başlanan yeni tanı meme kanserli hastalarda oksidatif stres ve antioksidan parametrelerin değerlendirilmesi / Evaluation of oxidative stress and antioxidant parameters in patients with adriablastin-cyclophosphamide chemotherapy began for newly diagnosed breast cancer

dc.contributor.advisor	DOÇ. DR. EMİN TAMER ELKIRAN
dc.contributor.author	NİHAT ALKAN
dc.date.accessioned	2019-06-03T17:12:42Z
dc.date.available	2019-06-03T17:12:42Z
dc.date.issued	2012
dc.identifier.uri	http://hdl.handle.net/11508/13247
dc.language.iso	Türkçe
dc.title	Adriyamisin-siklofosfamid kemoterapisi başlanan yeni tanı meme kanserli hastalarda oksidatif stres ve antioksidan parametrelerin değerlendirilmesi / Evaluation of oxidative stress and antioxidant parameters in patients with adriablastin-cyclophosphamide chemotherapy began for newly diagnosed breast cancer
dc.contributor.YOKID	424792
dc.relation.publishinghaddress	İç Hastalıkları Anabilim Dalı
dc.published.type	Ulusal